Analyst Price Target is $12.50
▲ +21.24% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Aurinia Pharmaceuticals in the last 3 months. The average price target is $12.50, with a high forecast of $14.00 and a low forecast of $11.00. The average price target represents a 21.24% upside from the last price of $10.31.
Current Consensus is
The current consensus among 5 contributing investment analysts is to buy stock in Aurinia Pharmaceuticals. This Buy consensus rating has held steady for over two years.